Latest News

Study: Often overlooked, molecules called glycans regulate COVID-19 spike protein function
9/26/22
New research highlights the role of molecules called N-glycans in SARS-CoV-2 infectivity — and as potential drug targets.
POP Biotechnologies' SNAP vaccine platform enters large-scale phase III clinical trials for COVID-19
9/21/22
Newswire and other websites report that UB spinoff POP Biotechnologies announced the start of two phase 3 clinical studies of EuCorVac-19, a COVID-19 vaccine candidate the startup is developing with South Korean partner EuBiologics.
UB neurosurgeons innovate powerful new ways to attack multiple blood clots deep in the veins of the brain
9/14/22
The UB team that a decade ago helped usher in a new era in acute stroke treatment has turned its innovative approach to addressing the rare but potentially deadly phenomena when multiple blood clots strike deep in the veins of the brain.
UB CAT invests $253,000 in six life sciences companies
9/12/22
The companies are developing treatments for cancer, neurovascular diseases and more.

UB Research News